서경진
#폐암#유방암#식도암#육종#비뇨기암#소화기암#기타고형암
|
학력
충북대학교 의과대학 의학과 졸업 (2010)
서울대학교 의과대학 의학과 석사 (2016)
서울대학교 의과대학 의학과 박사과정 (2016~)
서울대학교 의과대학 의학과 석사 (2016)
서울대학교 의과대학 의학과 박사과정 (2016~)
경력
서울대학교병원 내과 전공의 (2011-2015)
서울대학교병원 혈액종양내과 전임의 (2015-2017)
분당서울대학교병원 혈액종양내과 진료전문의 (2017-2018)
분당서울대학교병원 혈액종양내과 조교수(2018-현재)
서울대학교병원 혈액종양내과 전임의 (2015-2017)
분당서울대학교병원 혈액종양내과 진료전문의 (2017-2018)
분당서울대학교병원 혈액종양내과 조교수(2018-현재)
논문
Suh KJ, Kim SH, Lee KH, Kim TY, Kim YJ, Han SW, Kang E, Kim EK, Kim K, No JH, Han W, Noh DY, Lee M, Kim HS, Im SA, Kim JH. Bilateral Salpingo-Oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor-Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors. Cancer Res Treat. 2017 Feb 27. doi: 10.4143/crt.2016.463. [Epub ahead of print]
Suh KJ, Cheong JW, Kim I, Kim HJ, Shin DY, Koh Y, Yoon SS, Min YH, Ahn JS, Kim YK, Lee YG, Lee JO, Bang SM, Mun YC, Seong CM, Park Y, Kim BS, Hong J, Park J, Lee JH, Kim SY, Lee HG. Prognostic Impact of IPSS-R and Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome. PLoS One. 2016 Nov 8;11(11):e0166245. doi: 10.1371/journal.pone.0166245.
Suh KJ, Ryu HS, Lee KH, Kim H, Min A, Kim TY, Yang Y, Moon HG, Han SW, Oh DY, Han W, Park IA, Noh DY, Im SA. Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancer. Breast Cancer Res Treat. 2016 Jul;158(2)233-41
Suh KJ, Keam B, Kim M, Park YS, Kim TM, Jeon YK, Kim DW, Chung DH, Kim YW, Heo DS. Serum Neuron-Specific Enolase Levels Predict the Efficacy of First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Patients With Non-Small Cell Lung Cancer Harboring EGFR Mutations. Clin Lung Cancer. 2016 Jul;17(4):245-252
Suh KJ, Kim KH, Lim J, Park JH, Kim J-S, Choi IS. Lung cancer in Homeless People: Clinical Outcomes and Cost Analysis in a Single Institute. Canadian Respiratory Journal. 2016;2016:3727689. doi: 10.1155/2016/3727689. Epub 2016 Apr 27.
Suh KJ, Kim I, Lim J, Ha H, Park S, Koh Y, Yoon SS, Park S. Total costs and clinical outcome of hematopoietic stem cell transplantation in adults with leukemia: comparison between reduced-intensity and myeloablative conditioning. Clin Transplant. 2015 Feb;29(2):124-33.
Suh KJ, Park JK, Cho S, Park H, Baek HW, Lee K, Lee DS, Lee KH. Dermatomyositis in a Patient with Cholangiocarcinoma Detected by an [(18)F]-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Scan. Cancer Res Treat. 2016 Apr;48(2):848-52.
Suh KJ, Keam B, Im J, Kim MS, Lee DW, Kim DY, Wu HG. Solitary Splenic Metastasis from Head and Neck Cancer: A Case Report. Korean J Med. 2013 Sep;85(3):324-328. English. http://dx.doi.org/10.3904/kjm.2013.85.3.324
Beom SH, Oh J, Kim TY, Lee KH, Yang Y, Suh KJ, Moon HG, Han SW, Oh DY, Ha W, Kim TY, Noh DY, Im SA. Efficacy of Letrozole as First-line Treatment of Postmenopausal Women with Hormone Receptor-positive Metastatic Breast Cancer in Korea. Cancer Res Treat. 2016 Aug 23. doi: 10.4143/crt.2016.259. [Epub ahead of print]
Yang Y, Im SA, Keam B, Lee KH, Kim TY, Suh KJ, Ryu HS, Moon HG, Han SW, Oh DY, Han W, Kim TY, Park IA, Noh DY. Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses. BMC Cancer. 2016 Jul 21;16:515. doi: 10.1186/s12885-016-2500-1.
Chung YR, Kim H, Park SY, Park IA, Jang JJ, Choe JY, Jung YY, Im SA, Moon HG, Lee KH, Suh KJ, Kim TY, Noh DY, Han W, Ryu HS. Distinctive role of SIRT1 expression on tumor invasion and metastasis in breast cancer by molecular subtype. Hum Pathol. 2015 Jul;46(7):1027-35.
Lim J, Kim KH, Suh KJ, Yoh KA, Moon JY, Kim JE, Roh EY, Choi IS, Kim JS, Park JH. A Unique Case of Erdheim-Chester Disease with Axial Skeleton, Lymph Node, and Bone Marrow Involvement. Cancer Res Treat. 2016 Jan;48(1):415-21.
Lee HJ, Seo AN, Kim EJ, Jang MH, Suh KJ, Ryu HS, Kim YJ, Kim JH, Im SA, Gong G, Jung KH, Park IA, Park SY. HER2 heterogeneity affects trastuzumab responses and survival in patients with HER2-positive metastatic breast cancer. Am J Clin Pathol. 2014 Dec;142(6):755-66.
Lee JK, Hahn S, Kim DW, Suh KJ, Keam B, Kim TM, Lee SH, Heo DS. Epidermal growth factor receptor tyrosine kinase inhibitors vs conventional chemotherapy in non-small cell lung cancer harboring wild-type epidermal growth factor receptor: a meta-analysis. JAMA. 2014 Apr 9;311(14):1430-7
Kim M, Lee DW, Im J, Suh KJ, Keam B, Moon HG, Im SA, Han W, Park IA, Noh DY. Adenoid cystic carcinoma of the breast: a case series of six patients and literature review. Cancer Res Treat. 2014 Jan;46(1):93-7.
Suh KJ, Cheong JW, Kim I, Kim HJ, Shin DY, Koh Y, Yoon SS, Min YH, Ahn JS, Kim YK, Lee YG, Lee JO, Bang SM, Mun YC, Seong CM, Park Y, Kim BS, Hong J, Park J, Lee JH, Kim SY, Lee HG. Prognostic Impact of IPSS-R and Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome. PLoS One. 2016 Nov 8;11(11):e0166245. doi: 10.1371/journal.pone.0166245.
Suh KJ, Ryu HS, Lee KH, Kim H, Min A, Kim TY, Yang Y, Moon HG, Han SW, Oh DY, Han W, Park IA, Noh DY, Im SA. Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancer. Breast Cancer Res Treat. 2016 Jul;158(2)233-41
Suh KJ, Keam B, Kim M, Park YS, Kim TM, Jeon YK, Kim DW, Chung DH, Kim YW, Heo DS. Serum Neuron-Specific Enolase Levels Predict the Efficacy of First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Patients With Non-Small Cell Lung Cancer Harboring EGFR Mutations. Clin Lung Cancer. 2016 Jul;17(4):245-252
Suh KJ, Kim KH, Lim J, Park JH, Kim J-S, Choi IS. Lung cancer in Homeless People: Clinical Outcomes and Cost Analysis in a Single Institute. Canadian Respiratory Journal. 2016;2016:3727689. doi: 10.1155/2016/3727689. Epub 2016 Apr 27.
Suh KJ, Kim I, Lim J, Ha H, Park S, Koh Y, Yoon SS, Park S. Total costs and clinical outcome of hematopoietic stem cell transplantation in adults with leukemia: comparison between reduced-intensity and myeloablative conditioning. Clin Transplant. 2015 Feb;29(2):124-33.
Suh KJ, Park JK, Cho S, Park H, Baek HW, Lee K, Lee DS, Lee KH. Dermatomyositis in a Patient with Cholangiocarcinoma Detected by an [(18)F]-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Scan. Cancer Res Treat. 2016 Apr;48(2):848-52.
Suh KJ, Keam B, Im J, Kim MS, Lee DW, Kim DY, Wu HG. Solitary Splenic Metastasis from Head and Neck Cancer: A Case Report. Korean J Med. 2013 Sep;85(3):324-328. English. http://dx.doi.org/10.3904/kjm.2013.85.3.324
Beom SH, Oh J, Kim TY, Lee KH, Yang Y, Suh KJ, Moon HG, Han SW, Oh DY, Ha W, Kim TY, Noh DY, Im SA. Efficacy of Letrozole as First-line Treatment of Postmenopausal Women with Hormone Receptor-positive Metastatic Breast Cancer in Korea. Cancer Res Treat. 2016 Aug 23. doi: 10.4143/crt.2016.259. [Epub ahead of print]
Yang Y, Im SA, Keam B, Lee KH, Kim TY, Suh KJ, Ryu HS, Moon HG, Han SW, Oh DY, Han W, Kim TY, Park IA, Noh DY. Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses. BMC Cancer. 2016 Jul 21;16:515. doi: 10.1186/s12885-016-2500-1.
Chung YR, Kim H, Park SY, Park IA, Jang JJ, Choe JY, Jung YY, Im SA, Moon HG, Lee KH, Suh KJ, Kim TY, Noh DY, Han W, Ryu HS. Distinctive role of SIRT1 expression on tumor invasion and metastasis in breast cancer by molecular subtype. Hum Pathol. 2015 Jul;46(7):1027-35.
Lim J, Kim KH, Suh KJ, Yoh KA, Moon JY, Kim JE, Roh EY, Choi IS, Kim JS, Park JH. A Unique Case of Erdheim-Chester Disease with Axial Skeleton, Lymph Node, and Bone Marrow Involvement. Cancer Res Treat. 2016 Jan;48(1):415-21.
Lee HJ, Seo AN, Kim EJ, Jang MH, Suh KJ, Ryu HS, Kim YJ, Kim JH, Im SA, Gong G, Jung KH, Park IA, Park SY. HER2 heterogeneity affects trastuzumab responses and survival in patients with HER2-positive metastatic breast cancer. Am J Clin Pathol. 2014 Dec;142(6):755-66.
Lee JK, Hahn S, Kim DW, Suh KJ, Keam B, Kim TM, Lee SH, Heo DS. Epidermal growth factor receptor tyrosine kinase inhibitors vs conventional chemotherapy in non-small cell lung cancer harboring wild-type epidermal growth factor receptor: a meta-analysis. JAMA. 2014 Apr 9;311(14):1430-7
Kim M, Lee DW, Im J, Suh KJ, Keam B, Moon HG, Im SA, Han W, Park IA, Noh DY. Adenoid cystic carcinoma of the breast: a case series of six patients and literature review. Cancer Res Treat. 2014 Jan;46(1):93-7.
저서
저서 내용이 없습니다.
보도자료
보도자료 내용이 없습니다.
포스팅
포스팅 내용이 없습니다.
영상자료
영상자료 내용이 없습니다.
발표자료
발표자료 내용이 없습니다.